Whitegate Investment Counselors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-25,222
| Closed | -$2.06M | – | 158 |
|
2021
Q3 | $2.06M | Sell |
25,222
-850
| -3% | -$69.5K | 0.29% | 81 |
|
2021
Q2 | $2.38M | Sell |
26,072
-375
| -1% | -$34.2K | 0.34% | 76 |
|
2021
Q1 | $2.26M | Sell |
26,447
-350
| -1% | -$29.9K | 0.34% | 74 |
|
2020
Q4 | $2.53M | Sell |
26,797
-2,150
| -7% | -$203K | 0.41% | 63 |
|
2020
Q3 | $2.52M | Hold |
28,947
| – | – | 0.46% | 61 |
|
2020
Q2 | $2.53M | Sell |
28,947
-150
| -0.5% | -$13.1K | 0.51% | 63 |
|
2020
Q1 | $2.4M | Sell |
29,097
-2,250
| -7% | -$186K | 0.58% | 56 |
|
2019
Q4 | $2.97M | Sell |
31,347
-125
| -0.4% | -$11.8K | 0.54% | 63 |
|
2019
Q3 | $2.74M | Sell |
31,472
-543
| -2% | -$47.2K | 0.54% | 65 |
|
2019
Q2 | $2.92M | Sell |
32,015
-11,259
| -26% | -$1.03M | 0.59% | 64 |
|
2019
Q1 | $3.73M | Sell |
43,274
-3,817
| -8% | -$329K | 0.77% | 43 |
|
2018
Q4 | $3.62M | Sell |
47,091
-530
| -1% | -$40.8K | 0.84% | 38 |
|
2018
Q3 | $3.68M | Buy |
47,621
+6
| +0% | +$463 | 0.75% | 44 |
|
2018
Q2 | $3.22M | Buy |
47,615
+167
| +0.4% | +$11.3K | 0.66% | 52 |
|
2018
Q1 | $3.44M | Buy |
47,448
+246
| +0.5% | +$17.8K | 0.73% | 43 |
|
2017
Q4 | $3.55M | Sell |
47,202
-1,111
| -2% | -$83.6K | 0.74% | 42 |
|
2017
Q3 | $3.72M | Buy |
48,313
+56
| +0.1% | +$4.31K | 0.82% | 38 |
|
2017
Q2 | $3.61M | Buy |
48,257
+112
| +0.2% | +$8.38K | 0.82% | 38 |
|
2017
Q1 | $3.2M | Sell |
48,145
-921
| -2% | -$61.3K | 0.77% | 42 |
|
2016
Q4 | $3.2M | Sell |
49,066
-74
| -0.2% | -$4.83K | 0.86% | 38 |
|
2016
Q3 | $3.48M | Sell |
49,140
-1,451
| -3% | -$103K | 0.95% | 33 |
|
2016
Q2 | $3.74M | Buy |
+50,591
| New | +$3.74M | 1.04% | 32 |
|
2014
Q1 | $3.15M | Buy |
+48,582
| New | +$3.15M | 0.86% | 39 |
|